➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Colorcon
Johnson and Johnson
Medtronic
Mallinckrodt

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Litigation Details for 360Heros, Inc. v. GoPro, Inc. (D. Del. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

360Heros, Inc. v. GoPro, Inc. (D. Del. 2017)

Docket   Start Trial Date Filed 2017-09-13
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To
Jury Demand Plaintiff Referred To
Patents 10,004,812; 10,005,779; 10,006,924; 10,028,910; 10,028,925; 10,031,080; 10,031,144; 10,039,758; 10,039,779; 10,039,910; 10,046,058; 10,065,779; 10,066,003; 10,066,019; 10,072,053; 10,072,065; 10,085,924; 10,086,005; 10,086,010; 10,086,011; 10,086,046; 10,086,065; 10,086,072; 10,086,076; 10,111,874; 10,112,021; 10,115,021; 10,119,132; 10,119,171; 10,144,776; 10,144,779; 10,144,812; 10,300,010; 10,300,016; 10,300,039; 10,300,058; 10,300,065; 10,300,138; 10,300,139; 10,545,138; 6,028,057; 6,050,908; 6,878,077; 6,878,080; 6,908,902; 7,022,014; 7,041,139; 7,119,061; 7,126,018; 7,126,019; 7,521,041; 7,572,776; 7,572,779; 7,776,007; 7,812,049; 7,901,878; 7,910,758; 7,910,781; 8,003,111; 8,003,126; 8,008,003; 8,008,006; 8,008,032; 8,008,074; 8,008,309; 8,013,002; 8,013,112; 8,017,074; 8,017,758; 8,022,036; 8,030,545; 8,039,009; 8,039,010; 8,039,030; 8,044,014; 8,044,046; 8,048,017; 8,048,035; 8,048,043; 8,062,044; 8,063,004; 8,063,008; 8,063,015; 8,063,031; 8,063,043; 8,138,309; 8,309,077; 8,309,126; 8,309,572; 8,545,878; 8,636,001; 8,779,004; 8,779,171; 8,901,086; 9,005,016; 9,011,908; 9,018,017; 9,022,022; 9,023,001; 9,024,007; 9,027,319; 9,028,005; 9,028,878; 9,035,031; 9,035,033; 9,035,115; 9,035,132; 9,050,309; 9,057,061; 9,061,003; 9,061,005; 9,061,044; 9,062,319; 9,072,781; 9,074,005; 9,074,007; 9,119,781; 9,132,003; 9,132,112; 9,132,138; 9,545,380; 9,572,779; 9,572,878; 9,878,017; 9,878,020; 9,878,046; 9,908,924; 9,910,046
Link to Docket External link to docket

Details for 360Heros, Inc. v. GoPro, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2020-05-22 144 Report and Recommendations circular or circumferential manner[,]” ('019 patent, col. 10:53-55 (emphasis added)), such that the “…surrounding water. ('019 patent, col. 23:4-8 (emphasis added)) And Claim 36 recites: …cols. 7:24-27, 8:55-57; 10:3-8, 10:53-55, 11:15-21, 12:6-12, 13:58-63, 16:4-11, 16:62-66)) The parties…924, 925 n.1 (3d Cir. 2006); Henderson v. Carlson, 812 F.2d 874, 878-79 (3d Cir. 1987). …thereafter. Section 112 of the Patent Act requires that a patent claim “particularly point[] out and External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Mallinckrodt
McKinsey
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.